ľ¹Ï¸£ÀûÓ°ÊÓ

The primary aim of our research group is to enhance the quality of life for patients and families with inherited cardiac diseases, especially cardiomyopathies. Our approach involves a comprehensive examination of all aspects of disease, including pathophysiologic mechanisms, genetic underpinnings, clinical manifestations, and therapeutic advancements.

Utilizing diverse model systems such as natural occurring animal models and induced pluripotent stem cells (iPSc), we delve into aspects of cardiac disease pathology to gain deeper insights and drive innovation in treatment strategies. The main strength lies in our team’s expertise across various disciplines, enabling us to conduct research seamlessly from laboratory to clinical application. This significantly expedites the translation of research findings into clinical practice, thereby enhancing patient care. Our PIs maintain robust partnerships with (inter)national research groups, facilitating the exchange of knowledge and resources. Within the Netherlands we work closely with all partners of the National Working Group of Cardiogenetics, leveraging collective expertise for greater impact.

People